v3.25.1
Condensed Statements of Convertible Preferred Stock and Stockholders’ Equity (Unaudited) - USD ($)
$ in Thousands
Series A Convertible Preferred Stock
Series B Convertible Preferred Stock
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Total
Balance at Dec. 31, 2023 $ 55,897 $ (55,073) $ (46) $ 778
Balance (in Shares) at Dec. 31, 2023 325,039        
Stock-based compensation expense 1,018     1,018
Issuance of common stock, net of issuance costs 1,804 1,804
Issuance of common stock, net of issuance costs (in Shares) 140,430        
Issuance of Series A preferred stock and warrants, net of issuance costs $ 3,300 254 3,554
Issuance of Series A preferred stock and warrants, net of issuance costs (in Shares) 256,968        
Release of restricted stock units
Release of restricted stock units (in Shares) 403        
Other comprehensive income 46 46
Net loss (3,576)   (3,576)
Balance at Mar. 31, 2024 $ 3,300 58,973 (58,649) 3,624
Balance (in Shares) at Mar. 31, 2024 256,968 465,872        
Balance at Dec. 31, 2024 $ 3,300 $ 452 $ 3 70,962 (68,746) 5,971
Balance (in Shares) at Dec. 31, 2024 256,968 86,454 3,138,804        
Stock-based compensation expense 872 872
Issuance of common stock, pre-funded warrants and warrants under inducement agreement, net of issuance costs $ 3 2,732 2,735
Issuance of common stock, pre-funded warrants and warrants under inducement agreement, net of issuance costs (in Shares) 2,445,700        
Issuance of common stock, prefunded warrants, and warrants, net of issuance costs $ 2 3,522 3,524
Issuance of common stock, prefunded warrants, and warrants, net of issuance costs (in Shares) 2,005,000        
Release of restricted stock units
Release of restricted stock units (in Shares) 461        
Deferred deal costs (110) (110)
Deferred deal costs (in Shares)          
Net loss (3,616)   (3,616)
Balance at Mar. 31, 2025 $ 3,300 $ 452 $ 8 $ 77,978 $ (72,362) $ 9,376
Balance (in Shares) at Mar. 31, 2025 256,968 86,454 7,589,965